Chapter 27 — Case Study 2: α-Carbon Chemistry in Amino Acid Metabolism (PLP Enzymes)

"Vitamin B6 (pyridoxal phosphate, PLP) is the most chemically versatile cofactor in the cell. It enables transamination, racemization, decarboxylation, β-elimination — all by a single mechanism: α-H abstraction from a Schiff base." — Walsh, Enzymatic Reaction Mechanisms

The α-carbon of an amino acid is the chiral center that defines L vs D configuration. Most amino acids in proteins are L; in the body, conversion between L and D forms (racemization) is enzyme-catalyzed and tightly regulated. Enzymes also catalyze transamination (transferring the amino group from one carbonyl to another), decarboxylation (removing the COOH as CO₂), and β-elimination (removing a side chain) at the amino acid α-position.

All of these enzymes use pyridoxal phosphate (PLP, vitamin B6) as a cofactor. The chemistry is a beautiful application of α-carbon chemistry from this chapter — and it traces back to the same logic of enol/enolate stabilization.

PLP: structure and role

Pyridoxal phosphate is an aldehyde (PLP). Its structure: - A pyridine ring (6-membered N-containing aromatic) - A free aldehyde (-CHO) at one position - A hydroxyl, methyl, and methylene-phosphate group around the ring.

The free aldehyde is the key functional group: it forms a Schiff base (imine, Ch 25) with the α-amine of an amino acid. After Schiff base formation, the substrate is "loaded" onto the enzyme.

The Schiff base + α-H removal

When an amino acid (e.g., L-alanine) binds an enzyme via PLP, the α-amine attacks PLP's aldehyde:

$$\text{PLP-CHO} + H_2N-CHR-COOH \to \text{PLP-CH=N-CHR-COOH (Schiff base)} + H_2O$$

The Schiff base places the amino acid's α-C two bonds away from PLP's pyridine ring. Through the conjugated π system (PLP's pyridinium + Schiff base C=N + α-C), the α-H of the amino acid becomes much more acidic. Why?

The conjugate base of the α-H is stabilized by the entire conjugated system. The negative charge at the α-C can delocalize into the pyridinium ring's π* system. This pulls the α-H pKa from ~30 (free amino acid in water) down to ~10 (PLP-bound). Now an enzyme base can remove the α-H easily.

Mechanism Map: PLP α-H removal.

  1. Amino acid + PLP-aldehyde → Schiff base + water (imine formation, Ch 25).
  2. Enzyme base (often a lysine ε-amine in the enzyme active site, generated by the original lysine that was first bound to PLP and then displaced) removes the α-H.
  3. The resulting "quinonoid intermediate" is a stabilized enolate-like structure where the α-C has a negative charge delocalized into the pyridinium ring.
  4. Various reactions proceed from this quinonoid: protonation gives racemization; rearrangement gives transamination; loss of CO₂ gives decarboxylation; β-elimination gives β-loss.

The quinonoid intermediate is the crucial reactive species. Its lifetime is microseconds to milliseconds, during which time the enzyme directs which subsequent reaction occurs.

The four PLP reactions

Transamination (the most common)

In transamination, the α-amino group is transferred from one amino acid to another (or to a keto acid):

$$\text{Ala} + \text{α-KG} \to \text{Pyr} + \text{Glu}$$

(L-Alanine + α-ketoglutarate → pyruvate + L-glutamate.)

Mechanism (with PLP): 1. Alanine binds PLP → Schiff base. 2. α-H removed; quinonoid intermediate. 3. The Schiff base shifts: now the α-C is the C=N center, and the amino group has migrated to PLP's C4'. (This is a "1,3-prototropic shift.") 4. Hydrolysis of this new Schiff base releases pyruvate (a keto acid) and pyridoxamine phosphate (PMP, the amino form of PLP). 5. PMP then forms a Schiff base with α-ketoglutarate; the reverse process gives glutamate and regenerates PLP.

Net: amino group transferred from alanine to α-ketoglutarate. Two enzymes (or two halves of one enzyme) accomplish this.

Transamination is critical for amino acid metabolism — it lets the cell shuffle nitrogen from one carbon skeleton to another.

Racemization (L ↔ D conversion)

For specific amino acids that need to be in D form (e.g., D-alanine in bacterial cell walls):

  1. L-Ala binds PLP.
  2. α-H removed; quinonoid intermediate.
  3. Reprotonation occurs from the opposite face of the planar α-C → D-Ala.

The quinonoid is achiral at the α-C; reprotonation can be from either face. Enzymes control the face by appropriate active-site geometry.

Racemase enzymes (like alanine racemase) use this chemistry. Bacteria use D-alanine for cell wall synthesis; humans don't. Vancomycin and similar antibiotics target the D-Ala-D-Ala dipeptide of bacterial cell walls.

Decarboxylation

For amino acids that are precursors to neurotransmitters (glutamate → GABA, histidine → histamine, tryptophan → tryptamine → serotonin):

  1. Amino acid binds PLP.
  2. α-H removed (or, more precisely, α-COOH removed as CO₂).
  3. Quinonoid intermediate has the α-C as a carbanion.
  4. Re-formation of the C-H gives an amine product (the decarboxylated form).

Mechanism: the COOH group on the α-C is the leaving group; the carbanion-like quinonoid intermediate ejects CO₂ rather than reprotonating. The result is an amine with one less carbon.

β-Elimination

For amino acids like serine, threonine, cysteine:

  1. Amino acid binds PLP.
  2. α-H removed; quinonoid intermediate.
  3. The β-substituent (-OH for serine, -SH for cysteine) is eliminated as the leaving group.
  4. The result is an α,β-unsaturated PLP-Schiff base.
  5. Hydrolysis gives the de-functionalized product (e.g., pyruvate from serine).

This is how serine is metabolized to pyruvate (with loss of -OH as water). Similar for cysteine (loss of H₂S) and threonine (loss of acetaldehyde).

The unifying principle

All four PLP reactions share the same first step: α-H removal from a PLP Schiff base. The diversity comes from what happens next:

  • Reprotonation on opposite face → racemization.
  • Tautomerization to a different Schiff base → transamination.
  • Loss of CO₂ → decarboxylation.
  • Loss of β-substituent → β-elimination.

The enzyme's active site directs which fate occurs. This is why PLP enzymes are so versatile: one cofactor + one chemistry, four (or more) possible outcomes.

Connection to Chapter 27

The chemistry of PLP enzymes is exactly the α-carbon chemistry of Chapter 27, but with biological catalysis:

  • The α-H of an amino acid is normally not very acidic (pKa ~30 for the free amino acid).
  • Forming a Schiff base with PLP lowers the α-H pKa by ~20 units (to ~10) by extending the conjugation.
  • Once acidic, the α-H is removed by an enzyme base.
  • The enolate-like (quinonoid) intermediate is stabilized.
  • Subsequent chemistry depends on the enzyme.

So PLP is a "pKa-lowering" cofactor — it transforms the α-position of an amino acid from a non-acidic site to an enolate-like center, accessible to enzyme catalysis. The chemistry is identical to the 1,3-dicarbonyl trick of malonic ester (placing two carbonyls around the α-C to stabilize the enolate).

Drug targets and inhibitors

Many PLP enzymes are drug targets:

  • GAD (glutamate decarboxylase): produces GABA. Inhibition causes seizures; deficiency is associated with stiff person syndrome.
  • DOPA decarboxylase: produces dopamine and serotonin from L-DOPA and 5-HTP. Co-administered with L-DOPA in Parkinson's disease (with carbidopa, an inhibitor that prevents peripheral conversion).
  • AGAT (alanine-glyoxylate aminotransferase): deficiency causes primary hyperoxaluria.
  • Alanine racemase: target for cycloserine, a tuberculosis drug.

Inhibitors of these enzymes typically work by blocking PLP binding or by mimicking the substrate (so they bind PLP but cannot react, or react to an irreversible adduct).

Take-home

  • Pyridoxal phosphate (PLP) is the cofactor for amino acid α-C chemistry.
  • It forms a Schiff base with the amino acid α-amine, extending the conjugation to the pyridinium ring.
  • The Schiff base lowers the α-H pKa by ~20 units (from ~30 to ~10), enabling enzyme catalysis.
  • The α-H is removed; a quinonoid (stabilized enolate-like) intermediate forms.
  • Subsequent fate of the quinonoid determines the reaction: racemization (reprotonation from opposite face), transamination (tautomerization), decarboxylation (loss of CO₂), or β-elimination (loss of side-chain).
  • This is exactly the α-carbon chemistry of Chapter 27 — α-H acidity, enolate formation, electrophile reaction — but in biological cofactor-mediated form.
  • PLP enzymes are critical drug targets: dopamine biosynthesis (Parkinson's), GABA biosynthesis (epilepsy), bacterial cell wall (antibiotics).